MUSCLE INVASIVE BLADDER CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boosts bladder cancer treatment in major trial
Disease control OngoingThis Phase III trial tests whether adding the immunotherapy drug atezolizumab to standard chemoradiotherapy helps people with muscle-invasive bladder cancer that hasn't spread. About 475 participants receive either chemoradiotherapy alone or with atezolizumab. The main goal is to…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Keytruda may let some bladder cancer patients avoid bladder removal
Disease control OngoingThis phase 2 trial is testing whether the immunotherapy drug Keytruda (pembrolizumab) can help people with muscle-invasive bladder cancer avoid having their bladder removed. About 46 participants will receive two cycles of Keytruda, then doctors will check if the cancer has compl…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New radiation technique aims to slash gut damage in bladder cancer patients
Disease control OngoingThis study tests a new type of daily radiation therapy for muscle-invasive bladder cancer that adapts to changes in the body each day. The goal is to see if this approach lowers the chance of diarrhea and other bowel problems compared to standard radiation. About 110 adults with …
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New bladder cancer cocktail aims to save the bladder
Disease control OngoingThis phase 2 trial is testing whether a combination of chemotherapy, an immunotherapy drug called toripalimab, and radiation can effectively treat muscle-invasive bladder cancer while allowing patients to keep their bladder. About 71 adults with this type of bladder cancer will r…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Bladder cancer drug combo trial pulled before it even started
Disease control TerminatedThis trial was designed to test two drugs—erdafitinib and atezolizumab—for people with muscle invasive bladder cancer who cannot take the standard chemotherapy drug cisplatin. Erdafitinib targets a specific gene change that can drive cancer growth, while atezolizumab helps the im…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC